MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-31-2026
Milestone Scientific Accounts Receivables 2011-2026 | MLSS
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Milestone Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 313 K | 694 K | 943 K | 1.08 M | 1.71 M | 1.98 M | 1.54 M | 802 K | 1.79 M | 1.54 M | 1.53 M | 979 K | 1.15 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.98 M | 313 K | 1.24 M |
Quarterly Accounts Receivables Milestone Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 551 K | 387 K | 662 K | 313 K | 591 K | 790 K | 912 K | 694 K | 1.09 M | 825 K | 1.06 M | 943 K | 968 K | 812 K | 979 K | 1.08 M | 1.08 M | 1.08 M | 1.08 M | 1.71 M | 1.71 M | 1.71 M | 1.71 M | 1.98 M | 1.98 M | 1.98 M | 1.98 M | 1.54 M | 1.54 M | 1.54 M | 1.54 M | 802 K | 802 K | 802 K | 802 K | 1.44 M | 1.86 M | 1.79 M | 1.79 M | 1.54 M | 1.54 M | 1.54 M | 1.54 M | 1.53 M | 1.53 M | 1.53 M | 1.53 M | 979 K | 979 K | 979 K | 979 K | 1.15 M | 1.15 M | 1.15 M | 1.15 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.98 M | 313 K | 1.23 M |
Accounts Receivables of other stocks in the Medical instruments industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
66.7 M | $ 28.22 | -2.32 % | $ 1.35 B |  USA |
 |
Baxter International
BAX
|
1.7 B | $ 17.24 | 3.61 % | $ 8.84 B | USA |
 |
Atrion Corporation
ATRI
|
23 K | - | - | $ 810 M | USA |
 |
BioLife Solutions
BLFS
|
9.17 M | $ 19.71 | 3.03 % | $ 908 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
7.31 M | $ 8.73 | -3.64 % | $ 21.2 M | USA |
 |
Haemonetics Corporation
HAE
|
203 M | $ 59.53 | -0.05 % | $ 3 B | USA |
 |
Harvard Bioscience
HBIO
|
16 M | $ 5.55 | 2.78 % | $ 246 M | USA |
 |
The Cooper Companies
COO
|
829 M | $ 71.73 | 2.97 % | $ 14.3 B | USA |
 |
iRhythm Technologies
IRTC
|
75.7 M | $ 120.49 | 1.57 % | $ 3.86 B | USA |
 |
Isoray
ISR
|
6 K | - | 0.03 % | $ 108 M | USA |
 |
Repro Med Systems
KRMD
|
6.21 M | $ 4.19 | -1.18 % | $ 194 M | USA |
 |
Masimo Corporation
MASI
|
141 M | $ 178.3 | -0.24 % | $ 9.5 B | USA |
 |
Microbot Medical
MBOT
|
159 K | $ 2.35 | 2.62 % | $ 108 M |  Israel |
 |
Merit Medical Systems
MMSI
|
204 M | $ 69.24 | 2.73 % | $ 4.1 B | USA |
 |
electroCore
ECOR
|
1.03 M | $ 6.21 | -7.45 % | $ 52.7 K | USA |
 |
Envista Holdings Corporation
NVST
|
430 M | $ 26.66 | 5.42 % | $ 4.48 B | USA |
 |
Pro-Dex
PDEX
|
16.4 M | $ 48.97 | -1.63 % | $ 161 M | USA |
 |
Glaukos Corporation
GKOS
|
39.8 M | $ 118.62 | 3.09 % | $ 5.75 B | USA |
 |
Predictive Oncology
POAI
|
32.1 K | - | - | $ 31.1 M | USA |
 |
ICU Medical
ICUI
|
181 M | $ 123.92 | 3.41 % | $ 3.05 B | USA |
 |
InfuSystem Holdings
INFU
|
16.9 M | $ 9.47 | 1.18 % | $ 196 M | USA |
 |
Intuitive Surgical
ISRG
|
1.53 B | $ 462.28 | 2.06 % | $ 165 B | USA |
 |
ResMed
RMD
|
576 M | $ 230.7 | 2.06 % | $ 33.7 B | USA |
 |
LeMaitre Vascular
LMAT
|
33.6 M | $ 112.41 | 1.89 % | $ 2.54 B | USA |
 |
Retractable Technologies
RVP
|
7.9 M | $ 0.68 | -4.59 % | $ 20.4 M | USA |
 |
Pulse Biosciences
PLSE
|
274 K | $ 19.06 | -4.51 % | $ 1.28 B | USA |
 |
STAAR Surgical Company
STAA
|
50.1 M | $ 20.88 | -1.0 % | $ 1.03 B | USA |
 |
STERIS plc
STE
|
1.04 B | $ 225.03 | 2.65 % | $ 22.2 B | USA |
 |
Stereotaxis
STXS
|
5.85 M | $ 1.93 | 4.32 % | $ 176 M | USA |
 |
NeuroMetrix
NURO
|
193 K | - | 5.05 % | $ 9.02 M | USA |
 |
Teleflex Incorporated
TFX
|
346 M | $ 119.03 | 3.05 % | $ 5.31 B | USA |
 |
Utah Medical Products
UTMD
|
3.52 M | $ 64.53 | 1.67 % | $ 209 M | USA |
 |
West Pharmaceutical Services
WST
|
574 M | $ 265.93 | 2.54 % | $ 19.2 B | USA |
 |
AngioDynamics
ANGO
|
42.9 M | $ 10.17 | 4.85 % | $ 415 M | USA |
 |
Becton, Dickinson and Company
BDX
|
2.99 B | $ 157.09 | 1.37 % | $ 45.2 B | USA |
 |
Nephros
NEPH
|
1.5 M | $ 2.91 | 4.68 % | $ 30.2 M | USA |
 |
OraSure Technologies
OSUR
|
22.2 M | $ 3.08 | 0.65 % | $ 226 M | USA |
 |
Repligen Corporation
RGEN
|
124 M | $ 119.77 | 3.89 % | $ 6.67 M | USA |